Investors unfazed by FDA’s Covid vaccine framework
And more biotech news brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got more news out of DC today – let’s get into it.
